KBC Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.95M Buy
126,417
+1,117
+0.9% +$61.4K 0.02% 405
2025
Q1
$8.86M Sell
125,300
-5,398
-4% -$382K 0.03% 370
2024
Q4
$8.59M Sell
130,698
-33,249
-20% -$2.19M 0.02% 412
2024
Q3
$11.5M Sell
163,947
-68,308
-29% -$4.8M 0.03% 354
2024
Q2
$19.1M Buy
232,255
+2,264
+1% +$186K 0.06% 250
2024
Q1
$20.1M Sell
229,991
-12,109
-5% -$1.06M 0.06% 245
2023
Q4
$23.3M Sell
242,100
-7,922
-3% -$764K 0.08% 235
2023
Q3
$22.1M Sell
250,022
-37,208
-13% -$3.29M 0.09% 226
2023
Q2
$24.9M Buy
287,230
+7,566
+3% +$656K 0.1% 189
2023
Q1
$27.2M Sell
279,664
-42,036
-13% -$4.09M 0.12% 174
2022
Q4
$33.3M Buy
321,700
+94,560
+42% +$9.79M 0.16% 146
2022
Q3
$19.3M Sell
227,140
-700
-0.3% -$59.3K 0.1% 208
2022
Q2
$18.9M Buy
227,840
+43,486
+24% +$3.6M 0.09% 232
2022
Q1
$14.2M Sell
184,354
-8,151
-4% -$628K 0.06% 284
2021
Q4
$17M Sell
192,505
-135,059
-41% -$11.9M 0.06% 280
2021
Q3
$25.3M Sell
327,564
-139,912
-30% -$10.8M 0.09% 222
2021
Q2
$39M Buy
467,476
+98,220
+27% +$8.2M 0.07% 266
2021
Q1
$27.9M Buy
369,256
+81,014
+28% +$6.12M 0.06% 317
2020
Q4
$139M Sell
288,242
-113,436
-28% -$54.7M 0.06% 296
2020
Q3
$30.6M Buy
401,678
+20,104
+5% +$1.53M 0.09% 220
2020
Q2
$47.1M Buy
381,574
+284,270
+292% +$35.1M 0.16% 147
2020
Q1
$8.22M Sell
97,304
-62,427
-39% -$5.28M 0.07% 276
2019
Q4
$13.5M Buy
159,731
+12,695
+9% +$1.07M 0.09% 266
2019
Q3
$9.91M Buy
147,036
+27,083
+23% +$1.83M 0.07% 313
2019
Q2
$10.3M Buy
119,953
+16,852
+16% +$1.44M 0.08% 294
2019
Q1
$9.16M Sell
103,101
-4,402
-4% -$391K 0.08% 313
2018
Q4
$9.15M Sell
107,503
-34,780
-24% -$2.96M 0.1% 247
2018
Q3
$13.8M Buy
142,283
+101,089
+245% +$9.8M 0.1% 236
2018
Q2
$3.88M Sell
41,194
-233,204
-85% -$22M 0.03% 456
2018
Q1
$22.2M Sell
274,398
-39,873
-13% -$3.23M 0.21% 122
2017
Q4
$28M Sell
314,271
-52,601
-14% -$4.69M 0.24% 110
2017
Q3
$34.1M Buy
366,872
+29,264
+9% +$2.72M 0.31% 79
2017
Q2
$30.7M Buy
337,608
+52,847
+19% +$4.8M 0.3% 89
2017
Q1
$25M Buy
284,761
+109,033
+62% +$9.57M 0.23% 108
2016
Q4
$14.6M Buy
175,728
+88,857
+102% +$7.36M 0.14% 172
2016
Q3
$8.04M Buy
86,871
+45,963
+112% +$4.25M 0.09% 246
2016
Q2
$3.18M Buy
40,908
+2,046
+5% +$159K 0.05% 422
2016
Q1
$3.21M Buy
38,862
+19,407
+100% +$1.6M 0.05% 389
2015
Q4
$2.04M Sell
19,455
-9,749
-33% -$1.02M 0.04% 468
2015
Q3
$3.08M Sell
29,204
-47,215
-62% -$4.97M 0.06% 339
2015
Q2
$10.5M Buy
76,419
+19,865
+35% +$2.72M 0.13% 195
2015
Q1
$7.05M Buy
56,554
+10,473
+23% +$1.31M 0.09% 253
2014
Q4
$4.17M Buy
46,081
+38,977
+549% +$3.52M 0.05% 396
2014
Q3
$512K Sell
7,104
-5,282
-43% -$381K 0.02% 742
2014
Q2
$771K Sell
12,386
-35,221
-74% -$2.19M 0.01% 805
2014
Q1
$3.25M Sell
47,607
-46,026
-49% -$3.14M 0.05% 387
2013
Q4
$6.59M Buy
93,633
+23,388
+33% +$1.65M 0.1% 261
2013
Q3
$5.07M Buy
70,245
+11,349
+19% +$819K 0.08% 305
2013
Q2
$3.28M Buy
+58,896
New +$3.28M 0.06% 374